Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001437749-24-029643
Filing Date
2024-09-20
Accepted
2024-09-20 08:08:38
Documents
5

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A nby20240919_defa14a.htm DEFA14A 56400
2 EXHIBIT 2.1 ex_725618.htm EX-2.1 577285
3 EXHIBIT 2.2 ex_725706.htm EX-2.2 21276
4 EXHIBIT 99.1 ex_725917.htm EX-99.1 16624
5 logo.jpg GRAPHIC 3886
  Complete submission text file 0001437749-24-029643.txt   678071
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33678 | Film No.: 241311721
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)